This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe
Save the date!
November 6–8, 2023Munich, Germany
Menu
keyboard_arrow_right

Day 1 - CET/CEST (Cent Europe Summer, GMT+2)

keyboard_arrow_leftSearch & Filter
search

Day 1 - CET/CEST (Cent Europe Summer, GMT+2)

search
07:45 - 08:0015 mins
Registration (All day)
Registration and badge Pick-up opens (All day)
    07:45 - 08:0015 mins
    Exhibition (All day)
    Exhibition opens (All day)
      07:45 - 08:0015 mins
      Breakfast (7:45-10:45)
      Light breakfast (7:45-10:45)
        09:30 - 10:0030 mins
        Business Development Track 1
        Reality check: Arriello launches new survey on pharma/biotechs’ early experiences of EMA’s new clinical trials information system (CTIS)
        • Laura Millichamp - Founder, InsideReg
        • Kieran O'Donnell - VP Global Drug Safety, Arriello
        • Nicola Kidman - Principal Consultant - Regulatory Affairs, Arriello
        10:00 - 18:30510 mins
        Partnering: One-to-one meetings 24/7
        Partnering: One-to-one meetings
          10:15 - 10:4530 mins
          Business Development Track 1
          Opening remarks
          • Anna Chrisman - Managing Director Pharma and Life Sciences, Informa Connect
          • Thomas Kralinski - State Secretary, Saxon State Ministry for Economic Affairs, Labour and Transport
          • Oliver Uecke - Chairman of the Board, biosaxony
          • Susanna Ling - VP Industry Partnerships and Sponsorship, Biotechnology Innovation Organization
          10:45 - 11:4560 mins
          Business Development Track 1
          Opening plenary session: Opportunities created by a bear market - There IS a silver lining
          • Hubert Birner - Managing Partner, TVM Capital
          • Werner Lanthaler - CEO, Evotec
          • Sander Slootweg - Managing Partner, Forbion
          • Stephanie Leouzon - Partner and Head of Torreya Europe, Torreya
          • Detlev Mennerich - SVP, heading Global BD&L, Boehringer Ingelheim
          • Christian Rommel - Head of PH Research & Development, Bayer AG
          • Philippe Lopes-Fernandes - Executive Vice President and Chief Business Officer, IPSEN
          12:00 - 12:2020 mins
          Business Development Track 1
          In conversation with Susanne Fiedler, Chief Commercial Officer, Organon
          • Ruth Ciesinger - Online Managing Editor, der Tagesspiegel
          • Susanne Fiedler - Chief Commercial Officer, Organon
          12:00 - 14:00120 mins
          Live Networking
          Lunch
            13:00 - 14:0060 mins
            Business Development Track 1
            Immuno-inflammation: a gateway to therapeutic areas and new partners
            • Duncan Emerton - Executive Director, Consulting, Citeline
            • Vishal Sahni - Director, Corporate Business Development & Strategy, H. Lundbeck A/S
            • Peng Leong - Chief Business Officer & Head of Brain Aging, BioAge Labs
            13:00 - 14:0060 mins
            Business Development Track 2
            From bench to bedside: the unique clinical pathway of CGT products
            • Shardha Millington - Consultant, Citeline
            • Charlotte Smerdon - Cell & Gene Centre of Excellence Lead, Portfolio Director Project Management, Veristat
            • Isabelle Scarabin - Director, Business Development & Licensing Officer, Bayer
            • Ulrike Köhl - Director, Fraunhofer Institut für Zelltherapie und Immunologie (IZI)
            14:00 - 15:1575 mins
            Business Development Track 2
            Company Presentations
              14:00 - 14:3030 mins
              Regional Showcases
              Austria – Where innovation moves mountains!
              • Marlis Müllner - Director R&D Investment, Austrian Business Agency
              • Eva Schlintl - Investment Manager, LISA – Life Science Austria on behalf of Austria Wirtschaftsservice GmbH
              • Peter Llewellyn-Davies - President, Biotech Austria
              • Detlev Mennerich - SVP, heading Global BD&L, Boehringer Ingelheim
              14:30 - 15:1545 mins
              Finance Track
              25 years of cycles: similarities and differences, company and fund performances, and the attempt of an outlook
              • Olivier Litzka - Partner, Andera Partners Life Sciences
              • Holger Reithinger - Partner, Forbion
              • John Haurum - Chairman, JSH Biotech Aps.
              • Matthias Kromayer - Managing Partner, MIG Capital AG
              • Uli Grabenwarter - Deputy Director, Equity Investments & Guarantees, EIF
              • Ulrica Slåne Bjerke - Founder and CIO, Arctic Aurora Life Science
              14:35 - 15:0530 mins
              Regional Showcases
              Co-create the next value with bio ecosystems in Japan
              • Yoshiaki Tsukamoto - Executive Director, Japan Bioindustry Association (JBA)
              • Hidetoshi Tahara - Vice President, Hiroshima University
              • Hiroyuki Akatsuka - Associate Director, Life Sciences Industry Division, Osaka Prefectural Government
              15:15 - 16:0045 mins
              Finance Track
              Next gen dealmakers – dealing with complexity
              • Sascha Berger - Partner, TVM Capital
              • Marianne Mertens - Partner, Apollo Health Ventures
              • Dmitrij Hristodorov - Partner, Forbion
              • Felice Verduyn-van Weegen - Partner, EQT group
              15:15 - 15:4530 mins
              Regional Showcases
              Saxony-Anhalt as center for protein biochemistry and biopharmaceuticals
              • Florian Settele - Head of Business Unit Precision Capturing, Navigo Proteins GmbH
              • Stephan Schilling - Head of the Department of Drug Design and Target Validation, Fraunhofer IZI
              • Sebastian Schuck - Global Director Business Development, Wacker Biotech GmbH
              • Stefan Schneider - EMA Head of Life Sciences, KPMG AG Wirtschaftsprüfungsgesellschaft
              15:30 - 16:3060 mins
              Business Development Track 2
              Spotlight on Saxony’s Biotech Ecosystem
              • Julia Busch-Casler - Head of the Digital Health, Fraunhofer IMW
              • Norman Gerstner - CEO, Biotype GmbH
              • Michael Thompson - CEO, DyNAbind GmbH
              • Oliver Uecke - COO, Lipotype GmbH
              • Isabel Antholz - Managing Director, Mannin GmbH
              • Kerstin Stangier - Senior Director Global Integrations, Azenta / GENEWIZ
              15:45 - 16:1530 mins
              Regional Showcases
              In high demand, but highly demanding. Current challenges in the development of anti-infectives
              • Michael Taeger - CEO, BMD Life Sciences GmbH
              • Yuri (Jurijus) Gleba - CEO, Nomad Bioscience GmbH
              • Victor Klimyuk - Managing Director/COO, Icon Genetics GmbH
              16:15 - 17:0045 mins
              Finance Track
              In collaboration with YVC Collective - Fireside Chat
              • Catello Somma - Associate, TVM Capital
              • Daniela Begolo - Principal, Inkef
              • Hubert Birner - Managing Partner, TVM Capital
              • Sander Slootweg - Managing Partner, Forbion
              16:30 - 16:4010 mins
              Live Networking
              Break and Breathe
                16:45 - 16:5510 mins
                Live Networking
                Stretch and Relax
                  18:00 - 21:00180 mins
                  Live Networking
                  Monday Networking Reception
                    Welcome Reception - October 23
                    NextDay 2
                    Filter
                    Streams
                    Formats
                    Choose Day